Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Anabolic steroid users may face higher risk of severe COVID-19.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Possible link between androgens and COVID-19 severity; more research needed.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.